Skip to main content
Equibles

Larson Financial Group LLC

Position in ANIX — Anixa Biosciences Inc

CIK 1731061 ST LOUIS, MO
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,400
+$110 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 62 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Larson Financial Group LLC holds $5,718,078 across 194 Biotechnology names. ANIX ranks #129 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,302 $646,742
2 INCY
Incyte Corp
 4,050 $459,108
3 TGTX
Tg Therapeutics, Inc.
 7,292 $400,622
4 REGN
Regeneron Pharmaceuticals, Inc.
 627 $390,959
5 EXEL
Exelixis, Inc.
 4,507 $245,225
6 IONS
Ionis Pharmaceuticals Inc
 3,000 $237,870
7 ALNY
Alnylam Pharmaceuticals, Inc.
 613 $184,531
8 JAZZ
Jazz Pharmaceuticals plc
 709 $170,847

All Filings in ANIX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,400 500
2026-03-31 $1,290 500
2025-12-31 $1,560 500
2025-09-30 $1,650 500
2025-06-30 $1,650 500
2025-03-31 $1,430 500
2024-12-31 $1,160 500
2024-09-30 $1,575 500
2024-06-30 $1,105 500
2024-03-31 $1,560 500
2023-12-31 $2,037 525
2023-09-30 $1,716 525
2023-06-30 $1,680 525
2023-03-31 $2,257 525
2022-12-31 $2,231 525
2022-09-30 $2,583 525
2022-06-30 $1,606 525
2022-03-31 $1,370 500